Glucotrack (GCTK) Debt to Equity (2016 - 2020)
Glucotrack's Debt to Equity history spans 7 years, with the latest figure at $0.02 for Q3 2020.
- For the quarter ending Q3 2020, Debt to Equity rose 108.86% year-over-year to $0.02, compared with a TTM value of $0.02 through Sep 2020, up 108.86%, and an annual FY2019 reading of -$0.14, down 131.02% over the prior year.
- Debt to Equity for Q3 2020 was $0.02 at Glucotrack, up from $0.02 in the prior quarter.
- The five-year high for Debt to Equity was $11.77 in Q2 2019, with the low at -$0.22 in Q3 2019.
- Average Debt to Equity over 5 years is $0.66, with a median of -$0.01 recorded in 2017.
- Biggest YoY gain for Debt to Equity was 116552.6% in 2019; the steepest drop was 1897.59% in 2019.
- Tracing GCTK's Debt to Equity over 5 years: stood at -$0.01 in 2016, then rose by 25.49% to -$0.01 in 2017, then plummeted by 431.0% to -$0.06 in 2018, then tumbled by 131.02% to -$0.14 in 2019, then skyrocketed by 114.19% to $0.02 in 2020.
- Per Business Quant, the three most recent readings for GCTK's Debt to Equity are $0.02 (Q3 2020), $0.02 (Q2 2020), and $0.02 (Q1 2020).